Publications in collaboration with researchers from Pierre and Marie Curie University (2)

2019

  1. Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma

    Leukemia

2013

  1. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): A randomised, open-label, phase 3 trial

    The Lancet Oncology, Vol. 14, Núm. 11, pp. 1055-1066